How Does Osteonecrosis About the Knee Progress in Young Patients with Leukemia?: A 2- to 7-year Study

Ovid Technologies (Wolters Kluwer Health) - Tập 468 - Trang 2454-2459 - 2010
E. J. Karimova1, A. Wozniak2, J. Wu2, M. D. Neel3, S. C. Kaste4,5
1Mallinckrodt Institute of Radiology, Washington University, St. Louis, USA
2Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, USA
3Department of Surgery, St. Jude Children’s Research Hospital, Memphis, USA
4Radiological Sciences, MSN #220, St Jude Children’s Research Hospital, Memphis, USA
5Department of Radiology, University of Tennessee Health Science Center, Memphis, USA

Tóm tắt

Osteonecrosis is a major treatment complication of pediatric leukemias owing to its potential to cause joint deterioration. Because of potential long-term effects of osteonecrosis on joints, information regarding its progression and collapse in different patients can be used to identify high-risk groups, advise the patients and parents of this complication, and potentially consider the risk for development of osteonecrosis in planning primary treatment. We therefore determined: (1) the incidence of joint collapse and/or pain in young patients with hematologic malignancies diagnosed with ON of the knee; (2) risk factors associated with collapse; and (3) the relationship between size and location of osteonecrotic knee lesions and the likelihood of joint collapse. We retrospectively reviewed 109 patients with hematologic malignancies and MRI-confirmed knee osteonecrosis. The median age was 11.5 years (range, 2.3–18.8 years) at primary diagnosis of hematologic malignancy and a median age of 13.4 years (range, 2.7–23.3 years) at diagnosis of osteonecrosis of the knee. For analyses, we used the first and last MR images. Minimum clinical followup was 2.3 years after diagnosis of knee osteonecrosis (median, 6 years; range, 2.3–7.17 years). Joint collapse occurred in 22% (24 of 109). Older age, pain at osteonecrosis presentation, and lesions extending to the articular surface of distal femoral epiphyses were associated with joint collapse. Younger patients and those without extensive femoral epiphyseal involvement have a better prognosis for osteonecrosis of the knee. Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

Tài liệu tham khảo

Aricò M, Boccalatte MF, Silvestri D, Barisone E, Messina C, Chiesa R, Santoro N, Tamaro P, Lippi A, Gallisai D, Basso G, De Rossi G; Associazione Italiana di Ematologia ed Oncologia Pediatrica. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica. 2003;88:747–753. Flachsmann R, Broom ND, Hardy AE, Moltschaniwskyj G. Why is the adolescent joint particularly susceptible to osteochondral shear fracture? Clin Orthop Relat Res. 2000;381:212–221. Karimova EJ, Kaste SC. MR imaging of osteonecrosis of the knee in children with acute lymphocytic leukemia. Pediatr Radiol. 2007;37:1140–1146. Karimova EJ, Rai SN, Deng X, Ingle DJ, Ralph AC, Neel MD, Kaste SC. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 1, observer agreement. AJR Am J Roentgenol. 2006;186:470–476. Karimova EJ, Rai SN, Howard SC, Neel M, Britton L, Pui CH, Kaste SC. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol. 2007;25:1525–1531. Karimova EJ, Rai SN, Ingle D, Ralph AC, Deng X, Neel MD, Howard SC, Pui CH, Kaste SC. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns. AJR Am J Roentgenol. 2006;186:477–482. Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009;114:121–128. Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Group. J Clin Oncol. 2000;18:3262–3272. Ojala AE, Lanning FP, Paakko E, Lanning BM, Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment. Med Pediatr Oncol. 1997;29:260–265. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741. Sakai T, Sugano N, Ohzono K, Matsui M, Hiroshima K, Ochi T. MRI evaluation of steroid- or alcohol-related osteonecrosis of the femoral condyle. Acta Orthop Scand. 1998;69:598–602. Stevens K, Tao C, Lee SU, Salem N, Vandevenne J, Cheng C, Neumann G, Valentin-Opran A, Lang P. Subchondral fractures in osteonecrosis of the femoral head: comparison of radiography, CT, and MR imaging. AJR Am J Roentgenol. 2003;180:363–368. Takao M, Sugano N, Nishii T, Miki H, Yoshikawa H. Spontaneous regression of steroid-related osteonecrosis of the knee. Clin Orthop Relat Res. 2006;452:210–215. Werner A, Jäger M, Schmitz H, Krauspe R. Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood. Klin Padiatr. 2003;215:332–337.